Drug:
Reaction: PNEUMONIA
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25105284 |
CA |
1 | |
Pneumonia, Immunosuppression, Pharyngitis, Rhinitis, Swollen joint count increased, Illness, Therapy partial responder, |
||||
SECUKINUMAB, |
||||
502 | 25105289 |
2 | ||
Pneumonia, Dizziness, |
||||
AMBRISENTAN, RIOCIGUAT, |
||||
503 | 25105432 |
US |
||
Pneumonia, |
||||
ELACESTRANT, ALBUTEROL SULFATE, ALBUTEROL, VENLAFAXINE HYDROCHLORIDE, SACUBITRIL AND VALSARTAN, TRASTUZUMAB, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, LORAZEPAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, PROCHLORPERAZINE, MELATONIN, SPIRONOLACTONE, |
||||
504 | 25105868 |
US |
72 | 2 |
Pneumonia, Pneumothorax, Platelet count increased, |
||||
GUSELKUMAB, |
||||
505 | 25105939 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Walking aid user, Spinal fusion surgery, Hip arthroplasty, Crohn^s disease, Rheumatoid arthritis, Rheumatoid factor positive, Retinitis, Bronchitis, Laryngitis, Ear infection, Nasopharyngitis, Sinusitis, Folliculitis, Upper respiratory tract infection, Infection, Helicobacter infection, Pneumonia, Wound infection, Breast cancer stage III, Prescribed underdose, Prescribed overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, ANTACID, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
506 | 25105943 |
DE |
64 | 2 |
Lymphoma, Pleurisy, Pneumonia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
507 | 25106059 |
GB |
80 | 1 |
Cardiac failure, Pneumonia, Acute kidney injury, Cerebrovascular accident, Cerebral infarction, Appendicitis, Abdominal pain, |
||||
TAFAMIDIS, |
||||
508 | 25106069 |
CA |
49 | 2 |
Cardiac flutter, Pneumonia, Psoriatic arthropathy, Off label use, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, FOLIC ACID, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE SULFATE, |
||||
509 | 25106073 |
CA |
84 | 1 |
Arthralgia, COVID-19, Dizziness, Dyspnoea, Fall, Fatigue, Headache, Intestinal ischaemia, Mononeuropathy multiplex, Musculoskeletal stiffness, Myalgia, Pneumonia, Off label use, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, APIXABAN, BISOPROLOL FUMARATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FUROSEMIDE, GABAPENTIN, HYDROCORTISONE ACETATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SPIRONOLACTONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
510 | 25106086 |
CA |
57 | 2 |
Cough, Pneumonia, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
511 | 25106125 |
CA |
59 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthritis, Bone erosion, C-reactive protein increased, Condition aggravated, Contraindicated product administered, Crohn^s disease, Decreased appetite, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Ear infection, Exostosis, Maternal exposure during pregnancy, Fatigue, Foot deformity, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypoaesthesia, Incorrect route of product administration, Infection, Infusion related reaction, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lupus-like syndrome, Malaise, Mobility decreased, Musculoskeletal stiffness, Nausea, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Pneumonia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatoid arthritis, Rheumatoid factor positive, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Visual impairment, Wound, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BUPROPION HYDROCHLORIDE, BUPROPION, DICLOFENAC, DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, BUPROPION HYDROCHLORIDE, TOFACITINIB, SULFASALAZINE, |
||||
512 | 25106157 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Wheezing, Vomiting, |
||||
OMALIZUMAB, OMALIZUMAB, RITUXIMAB, CLONAZEPAM, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
513 | 25106391 |
US |
65 | 2 |
Vomiting, Pneumonia, Renal atrophy, Rhinorrhoea, Immunosuppression, |
||||
UPADACITINIB, UPADACITINIB, |
||||
514 | 25106395 |
JP |
15 | 2 |
Pancreatitis acute, Complications of transplanted kidney, Peripheral artery thrombosis, Pneumonia, Cytomegalovirus infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, BASILIXIMAB, RITUXIMAB, |
||||
515 | 25106420 |
US |
70 | 1 |
Pneumonia, Herpes zoster, |
||||
UPADACITINIB, |
||||
516 | 25106502 |
MX |
79 | 2 |
Deep vein thrombosis, Pneumonia, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
517 | 25106530 |
2 | ||
Pneumonia, Oesophageal haemorrhage, Haemoglobin decreased, |
||||
MOMELOTINIB, |
||||
518 | 25106547 |
US |
2 | |
Pneumonia, Blood immunoglobulin M decreased, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
519 | 25106551 |
US |
66 | 1 |
Pneumonia, Bradycardia, Influenza, |
||||
MAVACAMTEN, |
||||
520 | 25106590 |
CA |
65 | 2 |
Drug hypersensitivity, Pneumonia, Wheezing, Asthma, Dyspnoea, Oedema, Vomiting, |
||||
RITUXIMAB, OMALIZUMAB, CLONAZEPAM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MONTELUKAST, THEOPHYLLINE, CIPROFLOXACIN HYDROCHLORIDE, AMLODIPINE BESYLATE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, HYDROMORPHONE HYDROCHLORIDE, ROPIVACAINE HYDROCHLORIDE, ERGOCALCIFEROL, CALCIUM, TRAMADOL HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, PREDNISONE, |
||||
521 | 25106595 |
DE |
||
Shock haemorrhagic, Gastrointestinal haemorrhage, Pneumonia, Pancytopenia, Haematochezia, Sepsis, |
||||
OLAPARIB, EDOXABAN TOSYLATE, ALLOPURINOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, IRBESARTAN, |
||||
522 | 25106602 |
KR |
73 | 1 |
Pneumonia, |
||||
TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, TRIFLURIDINE AND TIPIRACIL, |
||||
523 | 25106645 |
US |
||
Pneumonia, |
||||
MEPOLIZUMAB, |
||||
524 | 25106682 |
US |
65 | 1 |
Pneumonia, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
525 | 25106701 |
ID |
||
Interstitial lung disease, Pneumonia, Cardiomegaly, Metastases to lung, |
||||
OSIMERTINIB, |
||||
526 | 25106722 |
CN |
||
Pneumonia, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
527 | 25106855 |
80 | 2 | |
Pneumonia, |
||||
ETANERCEPT, |
||||
528 | 25106859 |
81 | 2 | |
Pneumonia, White blood cell count decreased, Therapy interrupted, Muscle spasms, |
||||
LENALIDOMIDE, ALBUTEROL SULFATE, ALBUTEROL, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARVEDILOL, ERGOCALCIFEROL, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, APIXABAN, |
||||
529 | 25106901 |
US |
||
Pneumonia, Influenza, Asthma, |
||||
MEPOLIZUMAB, |
||||
530 | 25106972 |
US |
||
Pneumonia, |
||||
MEPOLIZUMAB, |
||||
531 | 25107243 |
CN |
||
Pneumonia, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
532 | 25107253 |
US |
2 | |
Pneumonia, Memory impairment, |
||||
DUPILUMAB, |
||||
533 | 25113035 |
68 | 1 | |
COVID-19, Pneumonia, |
||||
DEFERASIROX, |
||||
534 | 25113262 |
76 | 1 | |
Diarrhoea, Night sweats, Pneumonia, Hospitalisation, |
||||
APALUTAMIDE, |
||||
535 | 25113370 |
51 | 2 | |
COVID-19, Pneumonia, |
||||
ADALIMUMAB, |
||||
536 | 25113665 |
2 | ||
Pneumonia, Influenza, |
||||
OFATUMUMAB, |
||||
537 | 25113773 |
2 | ||
Pneumonia, Therapy interrupted, |
||||
MACITENTAN, |
||||
538 | 25114399 |
80 | 2 | |
Therapy interrupted, Pneumonia, |
||||
TERIPARATIDE, |
||||
539 | 25114594 |
75 | 2 | |
Pneumonia, |
||||
UPADACITINIB, |
||||
540 | 25097378 |
US |
73 | 1 |
Pneumonia, Dyspnoea, Cough, Influenza, |
||||
541 | 25097417 |
GB |
48 | 1 |
Pneumonia, Transplant dysfunction, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, RITUXIMAB, RITUXIMAB, |
||||
542 | 25097474 |
US |
1 | |
Pneumothorax, Arthritis, Pneumonia, Haemothorax, Arterial rupture, |
||||
ADALIMUMAB, |
||||
543 | 25097536 |
CA |
65 | 2 |
Dyspnoea, Pneumonia, Wheezing, Vomiting, Asthma, Drug hypersensitivity, Oedema, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, AMINOPHYLLINE, OMALIZUMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
544 | 25097680 |
CA |
40 | 2 |
Alopecia, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Depression, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fall, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Lip dry, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle spasms, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, APREMILAST, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
545 | 25097750 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
546 | 25097873 |
US |
||
Acute kidney injury, Hypokalaemia, Pneumonitis, Pneumonia, |
||||
SIROLIMUS, |
||||
547 | 25097919 |
CA |
2 | |
Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, X-ray abnormal, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, CALCIUM GLUCONATE, DESOGESTREL AND ETHINYL ESTRADIOL, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
548 | 25097936 |
CA |
13 | 1 |
Pneumonia, Ear infection, |
||||
INFLIXIMAB, |
||||
549 | 25097990 |
US |
88 | 1 |
Pneumonia, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, |
||||
550 | 25098046 |
CA |
69 | 2 |
Aspiration, Pneumonia, Vomiting, |
||||
SEMAGLUTIDE, ANASTROZOLE, ANASTROZOLE TABLETS, CALCIUM, DIMENHYDRINATE, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE, PRAVASTATIN SODIUM, PREGABALIN, REPAGLINIDE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, |
||||
551 | 25098119 |
US |
71 | 1 |
Pneumonia, Off label use, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
552 | 25098223 |
HK |
||
Peritonitis, Sepsis, Pneumonia, Respiratory failure, Systemic candida, Epstein-Barr viraemia, Cytomegalovirus syndrome, Polyomavirus viraemia, Pneumocystis jirovecii pneumonia, Cytomegalovirus viraemia, Viral infection, Urinary tract infection, Acute lymphocytic leukaemia, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOSPORINE, AZATHIOPRINE, |
||||
553 | 25098234 |
US |
2 | |
Pneumonia, Asthma, Impaired quality of life, Drug ineffective, |
||||
DUPILUMAB, AMOXICILLIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENALAPRIL, FLUTICASONE PROPIONATE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
554 | 25098260 |
JP |
77 | 1 |
Pneumonia, Blood glucose increased, Sepsis, Palmar-plantar erythrodysaesthesia syndrome, Pyrexia, |
||||
INSULIN HUMAN, INSULIN GLARGINE, SITAGLIPTIN, SITAGLIPTIN, |
||||
555 | 25098282 |
SG |
85 | 2 |
Pneumonia, |
||||
ADO-TRASTUZUMAB EMTANSINE, |
||||
556 | 25098313 |
CA |
49 | 2 |
Pneumonia, |
||||
GUSELKUMAB, |
||||
557 | 25098518 |
CA |
2 | |
Pneumonia, Abdominal pain, Vomiting, Pyrexia, |
||||
VEDOLIZUMAB, |
||||
558 | 25098537 |
US |
60 | 1 |
Pneumonia, Chest pain, Tremor, Rash vesicular, Injection site pain, |
||||
DUPILUMAB, CYCLOBENZAPRINE, ACETAMINOPHEN AND CODEINE, PREGABALIN, BUPRENORPHINE HYDROCHLORIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PIMECROLIMUS, |
||||
559 | 25098557 |
US |
||
Pneumonia, |
||||
NUSINERSEN, |
||||
560 | 25098618 |
US |
62 | 2 |
Pneumonia, Infusion site haemorrhage, Limb discomfort, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, GABAPENTIN, PROGESTERONE, VALACYCLOVIR HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, VITAMIN C, ESTRADIOL, ACETYLCYSTEINE, NIACIN, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, MOMETASONE FUROATE, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, CYCLOSPORINE, CARISOPRODOL, AZELASTINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, DEXLANSOPRAZOLE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, BUPROPION HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, THYROID, PORCINE, NABUMETONE, TIZANIDINE HYDROCHLORIDE, ERYTHROMYCIN, |
||||
561 | 25098735 |
CA |
40 | 2 |
Pericarditis, Pemphigus, Rheumatic fever, Peripheral venous disease, Psoriatic arthropathy, Pneumonia, Paraesthesia, Sleep disorder, Stomatitis, Rash, Peripheral swelling, Pain in extremity, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LAMOTRIGINE, LAMOTRIGINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MIRABEGRON, MIRABEGRON, TRAMADOL HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, NAPROXEN, NAPROXEN SODIUM, SECUKINUMAB, APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, CANDESARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ATOMOXETINE, OXYCODONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SARILUMAB, RANITIDINE, RANITIDINE, VITAMIN A, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, APREMILAST, APREMILAST, APREMILAST, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE BUTYRATE, USTEKINUMAB, USTEKINUMAB, BUPRENORPHINE, SULFASALAZINE, ERENUMAB-AOOE, MINOCYCLINE, MINOCYCLINE, MEPOLIZUMAB, PHENYLEPHRINE HYDROCHLORIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, RAMIPRIL, RAMIPRIL, RAMIPRIL, THIAMINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, NICOTINAMIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, AZATHIOPRINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, NAPROXEN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BOTULINUM TOXIN TYPE A, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLD, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
562 | 25098787 |
CA |
65 | 2 |
Pneumonia, Off label use, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, |
||||
563 | 25098937 |
CA |
2 | |
Pulmonary fibrosis, Wheezing, Stomatitis, Psoriatic arthropathy, Weight increased, Synovitis, Peripheral swelling, Rheumatoid arthritis, Pericarditis, Systemic lupus erythematosus, Weight decreased, Rash vesicular, Swelling, Wound, Pneumonia, Psoriasis, Sleep disorder due to general medical condition, insomnia type, Urticaria, Pyrexia, Wound infection, Rash, X-ray abnormal, Rheumatic fever, Sinusitis, Vomiting, Subcutaneous drug absorption impaired, Type 2 diabetes mellitus, Sleep disorder, Pemphigus, Pruritus, Rheumatoid factor positive, Swollen joint count increased, Pustular psoriasis, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, LISINOPRIL, DESOGESTREL AND ETHINYL ESTRADIOL, CALCIUM GLUCONATE, LANSOPRAZOLE, LORAZEPAM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ADALIMUMAB-ADAZ, RAMIPRIL, |
||||
564 | 25098940 |
US |
||
Influenza, Pneumonia, |
||||
BENRALIZUMAB, |
||||
565 | 25098973 |
CA |
65 | 1 |
Pneumonia, |
||||
GOLIMUMAB, |
||||
566 | 25098985 |
US |
||
Myasthenia gravis, Pneumonia, Fall, Oedema peripheral, Carbon dioxide increased, Abdominal distension, Poor quality sleep, |
||||
RAVULIZUMAB, |
||||
567 | 25099037 |
CA |
75 | 1 |
Pneumonia, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
568 | 25099040 |
US |
1 | |
Pneumonia, Muscular weakness, Cyst, Onychomadesis, Dry skin, Decreased appetite, Dry mouth, Dysphagia, Rash, Pruritus, Onychalgia, Pain in extremity, T-lymphocyte count decreased, Pain in extremity, |
||||
TALQUETAMAB, |
||||
569 | 25099086 |
US |
||
Pneumonia, |
||||
570 | 25099454 |
US |
64 | 2 |
Pneumonia, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
571 | 25099492 |
BG |
50 | 2 |
Pneumonia, Herpes zoster, Off label use, |
||||
GUSELKUMAB, |
||||
572 | 25099510 |
CO |
6 | 2 |
Pneumonia, Influenza like illness, Incorrect dose administered, Product prescribing error, |
||||
573 | 25099517 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, BISOPROLOL FUMARATE, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RITUXIMAB, RITUXIMAB, IRBESARTAN, IRBESARTAN, IRBESARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, RAMIPRIL, CANDESARTAN CILEXETIL, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, ERGOCALCIFEROL, LISINOPRIL, SITAGLIPTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DIMENHYDRINATE, DIMENHYDRINATE, ATORVASTATIN CALCIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, METHYLPREDNISOLONE, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, RAMIPRIL, LISINOPRIL, PROCHLORPERAZINE, LEVOTHYROXINE SODIUM, MORPHINE, ACITRETIN, AMLODIPINE BESYLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, LEVOTHYROXINE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, INSULIN DETEMIR, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
574 | 25099972 |
US |
83 | 2 |
Pneumonia, |
||||
DUPILUMAB, PREDNISONE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, APIXABAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZELASTINE HYDROCHLORIDE, AZELASTINE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, ALPRAZOLAM, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, VITAMIN C, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, GUAIFENESIN AND DEXTROMETHORPHAN, FUROSEMIDE, SIMVASTATIN, GABAPENTIN, LEVOTHYROXINE, MONTELUKAST SODIUM, MONTELUKAST, ENALAPRIL MALEATE, ENALAPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
575 | 25099998 |
CA |
60 | |
Asthma, Bronchitis, Dyspnoea, Loss of personal independence in daily activities, Malaise, Pneumonia, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, Illness, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, ALBUTEROL SULFATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, |
||||
576 | 25100029 |
US |
64 | 2 |
Influenza, Pneumonia, COVID-19, Septic shock, Diabetes mellitus, |
||||
BOSUTINIB, BOSUTINIB, BOSUTINIB, BOSUTINIB, |
||||
577 | 25100045 |
3 | 1 | |
Pyrexia, Diarrhoea, Pneumonia, Clostridium test positive, |
||||
MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, VINCRISTINE SULFATE, |
||||
578 | 25100251 |
US |
1 | |
Pneumonia, Product dose omission issue, |
||||
579 | 25100574 |
CA |
73 | |
Atrial fibrillation, Acute pulmonary oedema, Asthma, Diabetes mellitus, Dyspnoea, Hip arthroplasty, Loss of personal independence in daily activities, Pneumonia, Ventricular tachycardia, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, MONTELUKAST SODIUM, GLYCOPYRROLATE, PREDNISONE, |
||||
580 | 25100650 |
CA |
38 | 2 |
Pneumonia, |
||||
GUSELKUMAB, |
||||
581 | 25100745 |
US |
2 | |
Pneumonia, |
||||
PIMAVANSERIN TARTRATE, |
||||
582 | 25101037 |
44 | 2 | |
Pneumonia, Therapy interrupted, |
||||
ETANERCEPT, |
||||
583 | 25101093 |
US |
1 | |
Pneumonia, Immunoglobulins decreased, Product dose omission issue, Device malfunction, Sinusitis, Inability to afford medication, Insurance issue, Product use issue, Incorrect dose administered, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, INSULIN DETEMIR, NABUMETONE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
584 | 25101148 |
TW |
83 | 1 |
Cardiac amyloidosis, Pneumonia, Haemorrhage, Acute respiratory failure, Heart failure with preserved ejection fraction, Restrictive cardiomyopathy, Acquired ATTR amyloidosis, Dementia, Pleural effusion, Adrenal insufficiency, Cystitis, Acinetobacter infection, Escherichia infection, Skin infection, Eosinophilia, Drug eruption, Soft tissue infection, Urinary tract infection, Hypothyroidism, Aortic valve incompetence, Tricuspid valve incompetence, Aortic stenosis, Pulmonary hypertension, Ascites, Hyperbilirubinaemia, Hypertension, Off label use, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
585 | 25101171 |
PL |
78 | |
Pneumonia, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, ACETYLCYSTEINE, TELMISARTAN, INDAPAMIDE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
586 | 25101204 |
CA |
2 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pulmonary fibrosis, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Seronegative arthritis, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Tachycardia, Systemic lupus erythematosus, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Dyspnoea, |
||||
ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, AZATHIOPRINE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
587 | 25101360 |
US |
||
Death, Thrombocytopenia, Neutropenia, Leukopenia, Anaemia, Lymphopenia, Hyperglycaemia, Fatigue, Back pain, Hypocalcaemia, Infusion related reaction, Hypoalbuminaemia, Hyponatraemia, Aspartate aminotransferase increased, Dyspnoea, Headache, Hypophosphataemia, Pyrexia, Pneumonia, Pruritus, Hypertension, Plasma cell myeloma, Encephalopathy, Infection, Sinusitis, Hyperuricaemia, Therapy partial responder, Epistaxis, Chills, Therapy non-responder, Haemorrhage, Diarrhoea, Tachycardia, Nausea, Cough, Wheezing, |
||||
CARFILZOMIB, FILGRASTIM, DARATUMUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, |
||||
588 | 25101492 |
FR |
71 | 1 |
Confusional state, Pneumonia, Bicytopenia, |
||||
CARBOPLATIN, PEMBROLIZUMAB, FLUOROURACIL, |
||||
589 | 25101524 |
US |
79 | 2 |
Illness, Acute lymphocytic leukaemia recurrent, Respiratory failure, Cytopenia, Arteriosclerosis coronary artery, Pneumonia, Pneumothorax, Pleural effusion, Infection, |
||||
PREDNISONE, DASATINIB, DASATINIB, DASATINIB, NILOTINIB, BOSUTINIB, BOSUTINIB, METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, |
||||
590 | 25101543 |
US |
1 | |
Pneumonia, Intentional dose omission, |
||||
BIMEKIZUMAB, |
||||
591 | 25101565 |
BG |
47 | 2 |
Death, Pneumonia, |
||||
UPADACITINIB, |
||||
592 | 25101608 |
US |
77 | 2 |
Pneumonia, Influenza, |
||||
APIXABAN, GABAPENTIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, PAROXETINE HYDROCHLORIDE, PANTOPRAZOLE SODIUM, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, AMLODIPINE BESYLATE, ERGOCALCIFEROL, ACYCLOVIR, LEVOTHYROXINE, FEXOFENADINE HYDROCHLORIDE, LISINOPRIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
593 | 25101614 |
US |
2 | |
Respiratory syncytial virus infection, Pulmonary embolism, Pneumonia, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
594 | 25101649 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, ALISKIREN, ALISKIREN HEMIFUMARATE, AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, BISOPROLOL FUMARATE, CANDESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RITUXIMAB, RITUXIMAB, ZOLPIDEM TARTRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, CANDESARTAN CILEXETIL, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ERGOCALCIFEROL, DIMENHYDRINATE, DIMENHYDRINATE, SITAGLIPTIN, LEVOTHYROXINE, LEVOTHYROXINE, ATORVASTATIN CALCIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE, MORPHINE SULFATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, PREDNISONE, PROCHLORPERAZINE, RAMIPRIL, LEVOTHYROXINE SODIUM, LISINOPRIL, ACITRETIN, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, LEVOTHYROXINE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, INSULIN DETEMIR, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ROSUVASTATIN, USTEKINUMAB, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, |
||||
595 | 25101662 |
US |
73 | 2 |
Pneumonia, Influenza, Weight decreased, Diarrhoea, |
||||
LENALIDOMIDE, IXAZOMIB, |
||||
596 | 25101796 |
CZ |
57 | 2 |
Pneumonia, Rheumatoid arthritis, |
||||
CERTOLIZUMAB PEGOL, |
||||
597 | 25101817 |
GB |
1 | |
Pneumonia, |
||||
CLOZAPINE, |
||||
598 | 25101841 |
US |
78 | 2 |
Pneumonia, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
599 | 25102064 |
CL |
12 | 1 |
Cardio-respiratory arrest, Pneumonia, |
||||
NUSINERSEN, |
||||
600 | 25102144 |
US |
6 | 2 |
Unresponsive to stimuli, Pneumonia, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28